Darwin Advisors, LLC Johnson & Johnson Transaction History

Darwin Advisors, LLC

$197 Million
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $24,835 - $26,038	160 Added 5.68%	2,978 $471,000
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $31,449 - $34,318	-216 Reduced 7.12%	2,818 $441,000
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $3,893 - $4,362	-25 Reduced 0.82%	3,034 $472,000
Q2 2023 Jul 12, 2023	SELL	$154.35 - $166.11 $9,415 - $10,132	-61 Reduced 1.96%	3,059 $506,000
Q1 2023 Apr 18, 2023	SELL	$151.05 - $180.26 $7,099 - $8,472	-47 Reduced 1.48%	3,120 $483,000
Q4 2022 Jan 17, 2023	SELL	$160.2 - $179.79 $137,131 - $153,900	-856 Reduced 21.28%	3,167 $0
Q3 2022 Oct 18, 2022	SELL	$161.33 - $179.52 $8,873 - $9,873	-55 Reduced 1.35%	4,023 $670,000
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $1.3 Million - $1.44 Million	-7,722 Reduced 65.44%	4,078 $705,000
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $169,526 - $192,520	-1,072 Reduced 8.33%	11,800 $2.09 Million
Q4 2021 Jan 21, 2022	SELL	$155.93 - $173.01 $1.19 Million - $1.32 Million	-7,618 Reduced 37.18%	12,872 $2.13 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $93,670 - $104,092	-580 Reduced 2.75%	20,490 $3.31 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $1.82 Million - $1.95 Million	11,416 Added 118.25%	21,070 $3.47 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $9,337 - $10,399	61 Added 0.64%	9,654 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $19,880 - $22,820	-145 Reduced 1.49%	9,593 $1.51 Million
Q3 2020 Oct 16, 2020	SELL	$140.38 - $153.83 $118,199 - $129,524	-842 Reduced 7.96%	9,738 $1.45 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $93,902 - $113,366	-729 Reduced 6.45%	10,580 $1.49 Million
Q1 2020 May 01, 2020	SELL	$111.14 - $153.99 $23,783 - $32,953	-214 Reduced 1.86%	11,309 $1.48 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $108,630 - $124,766	-852 Reduced 6.88%	11,523 $1.68 Million
Q3 2019 Oct 16, 2019	SELL	$126.95 - $142.14 $2.2 Million - $2.46 Million	-17,323 Reduced 58.33%	12,375 $1.6 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $2.24 Million - $2.47 Million	17,097 Added 135.68%	29,698 $4.14 Million
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $31,555 - $35,087	251 Added 2.03%	12,601 $1.76 Million
Q4 2018 Jan 25, 2019	BUY	$122.84 - $147.84 $8,353 - $10,053	68 Added 0.55%	12,350 $1.59 Million
Q3 2018 Oct 23, 2018	SELL	$121.58 - $142.88 $20,060 - $23,575	-165 Reduced 1.33%	12,282 $1.69 Million
Q2 2018 Aug 16, 2018	BUY	$119.4 - $131.76 $117,728 - $129,915	986 Added 8.6%	12,447 $1.51 Million
Q1 2018 May 08, 2018	SELL	$125.1 - $148.14 $52,917 - $62,663	-423 Reduced 3.56%	11,461 $1.47 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $171,373 - $187,567	1,306 Added 12.35%	11,884 $1.66 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $1.37 Million - $1.43 Million	10,578	10,578 $1.38 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Account